Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
Hikaru Ota, Jun Takeuchi, Yuyako Nakano, Etsuyo Horiguchi, Yosuke Taki, Yasuki Ito, Hiroko Terasaki, Koji M. Nishiguchi, Keiko Kataoka
Topics & Concepts
AfliberceptMedicineMacular degenerationOphthalmologyRefractory (planetary science)Visual acuityExudative age-related macular degenerationFluorescein angiographyRanibizumabSurgeryBevacizumabChemotherapyAstrobiologyPhysicsRetinal Diseases and TreatmentsOphthalmology and Visual Impairment StudiesRetinal Imaging and Analysis